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Abstract
Background: Pancreatic panniculitis is a rare complication of pancreas disorders occurring in 0.3–3% of patients,
most often accompanied by the pancreatic acinar carcinoma.
It presents multiple, painful, deep, ill-defined, red-brown, migratory nodules and plaques of hard elastic consistency;
often ulcerated and typically located on the lower proximal and distal extremities.
The pathogenesis is not fully understood, but it is thought to result from lipolysis and fat necrosis with secondary
tissue inflammation induced by pancreatic enzymes. Histopathology shows subcutaneous lobular fat necrosis with
anuclear adipocytes (called ghost cells) surrounded by a mixed inflammatory infiltrate. Focal calcification may also be
seen. The treatment is directed to the underlying disorder, which may result in regression of skin lesions.
Case presentation: We present two cases of pancreatic panniculitis with similar clinical, laboratory, and histopathological
features associated with different internal malignancy. The first case, after extensive investigations showed the presence of
a pancreatic carcinoma with multiple liver metastases and a poor prognosis. The second one instead is the first case
in literature where painful subcutaneous nodules of the legs were the early manifestation of a neuroendocrine carcinoma
of the adrenal gland.
Conclusions: Although subcutaneous fat necrosis usually occurs late in the course of a malignancy, recognition of
the association with pancreatic panniculitis may prevent a long delay in the diagnosis and management of
the occult neoplasm. It should be primarily considered when panniculitis is widespread and persistent, and
frequent relapses or tendency to ulcerate of the nodules are regarded as red flags.
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Background
Pancreatic panniculitis (PP) is a rare entity described for
the first time by Chiari in 1883 [1], characterized by sub-
cutaneous fat necrosis. It occurs especially in males
(M:F = 4:1), with an average age of around 60 and with a
higher incidence among alcoholic patients [2]. It is most
frequently associated with pancreatic diseases, most
commonly acute or chronic pancreatitis and pancreatic
carcinoma (usually of acinar cells) [3, 4] and rarely other
pancreatic tumors, such as those of neuroendocrine ori-
gin [5]. These patients show ill-defined erythematous
subcutaneous nodules, more often localized in the lower
extremities [6]. The pathogenesis is still unknown, but it
is believed to be associated with high levels of serum lip-
ase produced by the neoplasm, causing fat necrosis in
tissues [7]. Because the skin lesions often precede the
onset of symptoms due to the underlying disease, it is
important to consider PP in patients with subcutaneous
nodules and elevated levels of pancreatic enzymes, in
order to avoid missed or significantly delayed diagnosis
[8]. We describe two cases characterized by similar clin-
ical features and an increase of lipase level, with histo-
pathologic features pathognomonic of PP. In both cases
skin manifestations were the presenting symptom of an
internal malignancy: a pancreatic carcinoma and a neu-
roendocrine carcinoma of the adrenal gland, which pro-
duce high levels of serum lipase responsible for fat
necrosis in tissues.* Correspondence: elena.guanziroli@hotmail.it
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Case Presentation
Case 1
A 77-year-old man presented to our Department with a
one-month-history of multiple and slightly painful nodules
on his lower legs. His medical history was significant for ar-
terial hypertension, dyslipidemia, and a heart attack and he
was in treatment with acetylsalicylic acid, diltiazem, lova-
statin and valsartan. Over the following two weeks he
noted an increasing number and worsening induration in
the nodules; thus, he saw his general practitioner who re-
ferred him to a dermatologist in a private practice for an
evaluation of the skin lesions. This colleague made a diag-
nosis of a panniculitis and started a treatment with pred-
nisone 25 mg daily, which was concluded without benefit.
On admission, physical examination revealed disseminated,
ill-defined, firm, erythematous and violaceous nodules
between 2 and 4 cm in diameter (Fig. 1a). A nodule on the
medial surface of the left leg presented a superficial pustule
and erosion (Fig. 1b). Some of the nodules resolved with
painless pigmentation. He was apyrexial with a blood pres-
sure 160/70 mmHg. The remaining physical examination
was unremarkable without evidence of organomegaly or
lymphoadenopathy. Laboratory investigations showed
highly elevated serum lipase levels (6027.2 U/l[13.0–60.0
nv]), with normal amylase, normocytic anemia (Haemo-
globin: 9.6 g/dl, MCV 87.9 fl), mild renal impairment
(Creatinine: 1.26 mg/dl), increase in inflammatory
markers (ESR: 69 mm; CRP: 6.07 mg/dl), elevated GGT
(163 mg/dl), and LDH (489 mg/dl) values.
Tumor markers (CEA, CA 19–9, PSA) were normal,
except for the AFP levels (202.7 ng/ml).A biopsy of a
subcutaneous nodule showed focal fat necrosis with
liquefaction phenomena of adipocytes, ghost-like cells
and calcium deposits consistent with PP (Fig. 2). In the
suspicion of a paraneoplastic syndrome, the patient, in
addition to blood tumor marker investigations, under-
went chest radiography (that resulted not significant) as
well as abdomen ultrasound, which revealed the pres-
ence of multiple focal lesions in the liver (2–7 cm of
diameter), and a solid inhomogeneous echostructure,
with a necrotic-colliquative central area. A contrast total
body computed tomographic (CT) scan confirmed the
neoplastic nature of these findings and showed a mass of
about 3 × 4 cm in the tail of the pancreas, referable in
the first hypothesis to the primary cancer.
The patient was subsequently referred to an oncolo-
gist, that in relation to the extension of the disease, ad-
ministered only supportive symptomatic therapy. His
condition severely deteriorated in the meantime and the
patient died two months later.
Case 2
An 85-year-old woman was admitted to our Department
with a 6-month history of painful erythematous nodules
located bilaterally on the legs, progressively developed
and worsened. The first diagnosis, made by an external
dermatologist, was erythema nodosum and the patient
was placed on systemic antibiotics and steroids therapy
with josamicin 2 g/day and prednisone 25 mg/day, lead-
ing however a worsening of the skin lesions.
The patient had good general condition and she just
took propafenone for previous episodes of ventricular ex-
trasystoles. She did not report any weight loss, fever, nau-
sea or vomiting, abdominal pain or problems with food
Fig. 1 Patient 1: multiple erythematous-brownish subcutaneous nodules on the legs (panel a); one of them shows an ulcerated surface
(panel b). Patient 2: erythematous-violaceous subcutaneous nodules surrounded by a purpuric halo on the lower extremities (panel c)
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intake. Her family history was significant for cardiovascu-
lar diseases. The physical examination revealed multiple
firm erythematous-violaceous nodules on the legs and the
ankles; of various sizes, from about 2 to 4 cm in diameter,
and painful (Fig. 1c). A deep biopsy taken from a lesion
showed a predominantly lobular panniculitis with lique-
factive fat necrosis and adipocytes saponification. Calcium
deposits were associated with pseudomembranes. Labora-
tory examinations showed an elevated concentration of
serum lipase (3467 U/l) with normal level of amylase. In-
flammatory markers were increased (ESR: 63 mm; CRP:
2.43 mg/dl; beta2 microglobulin 3.3 mg/dl), as well as
white blood cells (11.02 10 × 3/mmc). All other routine
tests and tumor markers (CEA, CA125, CA15.3, CA 19–
9, AFP) were normal. A total body CT scan was performed
to investigate the lipase increased and it showed a volu-
minous solid neoplasm of 8 cm in diameter at the level of
the left adrenal gland, which was not evident on the abdo-
men ultrasound, performed 6 months before. Ultrasound-
guided needle biopsy of the mass was performed and it
revealed a well-differentiated endocrine tumor (with this
immunohistochemical profile: Cytokeratin PAN (+),
Synaptophysin (+), Chromogranin (−), Cytokeratin 7 (−),
Vimentin (−), CD10 (−).
The patient was subsequently sent to an oncology op-
erating unit but she died of acute myocardical infarction
while she was waiting for surgery.
Discussion and Conclusions
The described cases are two different examples of PP.
In 40% of cases of PP, skin lesions precede the symp-
toms of underlying diseases and the interval between
cutaneous findings and discovery of abdominal disor-
ders goes from 1 to 7 months, [8, 9] an early and
proper diagnosis being thus crucial. PP usually presents
with erythematous-violaceus plaques and nodules pre-
dominantly located on the legs (around the ankles and
pretibial region), buttocks or trunk, which may resolve
spontaneously or may ulcerate, draining an oily brown,
sterile, viscous substance due to liquefactive fat necro-
sis. [10, 11]. Clinically, it is often difficult to make a dif-
ferential diagnosis between the various types of
panniculitis: especially erythema nodosum, lupus pan-
niculitis, panniculitides in sarcoidosis, and erythema
induratum/nodular vasculitis.
Considering the wide spectrum of differential diagnoses
a deep skin biopsy that includes the subcutaneous tissue is
mandatory for the diagnosis. Histopathological examin-
ation shows lobular fat necrosis with a predominantly
neutrophilic inflammatory infiltrate. Focal calcification
and anuclear adipocytes, within a thick, shadowy wall
(ghost cells) are characteristic [12]. Laboratory investiga-
tions usually reveal raised amylase, lipase and trypsin
levels and sometimes the presence of elevated tumor
marker levels, especially carcinoembryonic antigen [13].
Interestingly, in the first patient, elevated lipase were
found even though he had normal amylase. Although the
reason of this discrepancy remains unclear, there are other
similar cases in literature reporting the same blood
changes [12, 14]. Moreover, some cases of PP occurring in
patients with normal pancreatic enzymes have been re-
ported. It has been hypothesized that some patients are
unable to degrade pancreatic enzymes, possibly due to de-
ficiencies of enzymes like alpha-1 antitrypsin [12]. The
pathogenesis of pancreatic panniculitis is not fully under-
stood, but it seems that the release of high amounts of
pancreatic enzymes such as trypsin, amylase, lipase and
phospholipase may lead to a focal necrosis of lipids and a
concomitant inflammatory reaction [6, 15, 16]. Clinicians
should be aware that panniculitis may be the warning
signal of serious diseases, such as pancreatic cancer
or other types of cancer, and may precede the symp-
toms and signs typically related to these conditions.
Therefore, it is crucial to perform laboratory exams
and instrumental investigations to disclose the pres-
ence of underlying diseases [17].
Fig. 2 Predominant lobular panniculitis with focal fat necrosis (Panel a). Liquefaction phenomena of adipocytes, ghost-like cells and calcium deposits
in a predominant neutrofilic inflammatory infiltrate (Panel b, c)
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In the majority of the reported cases, this form of
panniculitis is caused by pancreatic diseases [18, 19],
the first case we described is a clear example of this.
Our second patient is instead a very unique case in
which the cause of panniculitis was an endocrine
tumor, localized in the adrenal system which produces
lipase. This is the first case in literature of a panniculitis
associated to an endocrine tumor of the adrenal gland.
The production of lipase by this tumor (3467 U/l was
the laboratory data of our patient) clearly leads to the
same clinical manifestation associated with pancreatic
diseases and the pathogenesis could be similar to pan-
niculitis caused by pancreatic cancers. Although sub-
cutaneous fat necrosis generally occurs late in the
course of a malignancy, recognition of the association
with PP may prevent a long delay in the diagnosis and
management of the occult neoplasm. It should be pri-
marily considered when panniculitis is widespread and
persistent, and frequent relapses or tendency to ulcer-
ate of the nodules are regarded as red flags.
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